Cytek Biosciences reports preliminary Q4 revenue of $62 million

Go back to Cytek Biosciences reports preliminary Q4 revenue of $62 million
(NASDAQ: CTKB) Delayed: 4.44 -0.37 (7.69%)
Previous Close $4.81    52 Week High
Open $4.80    52 Week Low
Day High $4.84    P/E N/A 
Day Low $4.29    EPS
Volume 943,483